{
  "title": "CANMAT Task Force Recommendations for the Use of Ketamine",
  "itunes:title": "CANMAT Task Force Recommendations for the Use of Ketamine",
  "pubDate": "Mon, 06 Jun 2022 16:00:20 +0000",
  "guid": "4256afdf-7426-4db0-9cd2-dc8956209df2",
  "link": "https://psychopharmacology.libsyn.com/canmat-task-force-recommendations-for-the-use-of-ketamine",
  "itunes:image": "",
  "description": "<p>Can we use ketamine as a maintenance treatment for MDD?<br /> In this episode, Dr. Phelps discusses CANMAT’s recommendations for the use of ketamine for MDD.</p> <p>Faculty: Jim Phelps, M.D.<br /> Host: Jessica Diaz, M.D.</p> <ul> <li><a href= \"https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC163\"> <strong>Learn more about our memberships here</strong></a></li> <li><a href= \"https://psychopharmacologyinstitute.com/publication/quick-take-vol-35-2632?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC163\"> <strong>Earn 0.5 CMEs: Quick Take Vol. 35</strong></a></li> <li><a href= \"https://psychopharmacologyinstitute.com/section/the-canadian-network-for-mood-and-anxiety-treatments-canmat-task-force-recommendations-for-the-use-of-racemic-ketamine-in-adults-with-major-depressive-disorder-2632-5169?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC163\"> <strong>The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults With Major Depressive Disorder</strong></a></li> </ul>",
  "content:encoded": "<p>Can we use ketamine as a maintenance treatment for MDD? In this episode, Dr. Phelps discusses CANMAT’s recommendations for the use of ketamine for MDD.</p> <p>Faculty: Jim Phelps, M.D. Host: Jessica Diaz, M.D.</p> <ul> <li><a href= \"https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC163\"> Learn more about our memberships here</a></li> <li><a href= \"https://psychopharmacologyinstitute.com/publication/quick-take-vol-35-2632?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC163\"> Earn 0.5 CMEs: Quick Take Vol. 35</a></li> <li><a href= \"https://psychopharmacologyinstitute.com/section/the-canadian-network-for-mood-and-anxiety-treatments-canmat-task-force-recommendations-for-the-use-of-racemic-ketamine-in-adults-with-major-depressive-disorder-2632-5169?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC163\"> The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults With Major Depressive Disorder</a></li> </ul>",
  "enclosure": "",
  "itunes:duration": "10:37",
  "itunes:explicit": false,
  "itunes:keywords": "",
  "itunes:subtitle": "Can we use ketamine as a maintenance treatment for MDD? In this episode, Dr. Phelps discusses CANMAT’s recommendations for the use of ketamine for MDD. Faculty: Jim Phelps, M.D. Host: Jessica Diaz, M.D.",
  "itunes:episodeType": "full"
}